Diagnostic News and Research

RSS
Greenwood launches Syndromic Autism 62-Gene Panel

Greenwood launches Syndromic Autism 62-Gene Panel

Navidea announces data from Lymphoseek Phase 3 study on oral and squamous cell cancers

Navidea announces data from Lymphoseek Phase 3 study on oral and squamous cell cancers

Accidental ingestion of wire bristles leads to necessity for surgery

Accidental ingestion of wire bristles leads to necessity for surgery

Bristol-Myers Squibb, Meso Scale Discovery collaborate to advance AD research

Bristol-Myers Squibb, Meso Scale Discovery collaborate to advance AD research

Affymetrix' GeneChip technology incorporated into Lineagen's FirstStepDx genetic evaluation service

Affymetrix' GeneChip technology incorporated into Lineagen's FirstStepDx genetic evaluation service

FDA clears BD MAX assay for detecting GBS DNA in Lim Broth cultures

FDA clears BD MAX assay for detecting GBS DNA in Lim Broth cultures

MabCure retains CUNY CAT to evaluate monoclonal antibodies against ovarian cancer

MabCure retains CUNY CAT to evaluate monoclonal antibodies against ovarian cancer

Greenway announces availability of PrimeMOBILE

Greenway announces availability of PrimeMOBILE

Strand Diagnostics to receive $30 million in funding from NantWorks

Strand Diagnostics to receive $30 million in funding from NantWorks

Chromosomal abnormality in children with ependymoma linked with poorer chance of survival

Chromosomal abnormality in children with ependymoma linked with poorer chance of survival

ASGE announces honorees of new endoscopy unit recognition program

ASGE announces honorees of new endoscopy unit recognition program

Clovis commences CO-1686 Phase I/II study in NSCLC

Clovis commences CO-1686 Phase I/II study in NSCLC

Inhibitory control test and lactulose for MHE saves more than $3 million over 5 years

Inhibitory control test and lactulose for MHE saves more than $3 million over 5 years

FDA approves Avioq HTLV-I/II Microelisa System

FDA approves Avioq HTLV-I/II Microelisa System

AMP confident in lawsuit to invalidate patents on two breast cancer genes

AMP confident in lawsuit to invalidate patents on two breast cancer genes

Cardiac CT more effective in evaluating ER patients with chest pain

Cardiac CT more effective in evaluating ER patients with chest pain

Therapy Finder - Colorectal Cancer app now available for patients

Therapy Finder - Colorectal Cancer app now available for patients

Researchers develop gut-on-a-chip microdevice

Researchers develop gut-on-a-chip microdevice

New microfluidic chip more effective in detecting flu outbreaks

New microfluidic chip more effective in detecting flu outbreaks

Vermillion fourth quarter total revenues increase 152% to $868,000

Vermillion fourth quarter total revenues increase 152% to $868,000

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.